Cargando…

Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort

BACKGROUND: Contradictory information exists regarding the influence of CYP2D6 polymorphisms on adverse drug reactions (ADRs) (extrapyramidal symptoms (EPS) and weight gain) related to risperidone treatment. This prompted us to evaluate the influence of CYP2D6 genetic variation in a cohort of South...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodgen, Tyren M., Eloff, Arinda, Mataboge, Connie, Roos, Louw (.J.L.)., van Staden, Werdie (.C.W.)., Pepper, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745369/ https://www.ncbi.nlm.nih.gov/pubmed/26937359 http://dx.doi.org/10.1016/j.atg.2015.05.001

Ejemplares similares

Allelic variants of the Melanocortin 4 receptor (MC4R) gene in a South African study group
por: Logan, Murray, et al.
Publicado: (2015)

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
por: Alessandrini, Marco, et al.
Publicado: (2016)

Achievements hitherto and a new editorial team for the South African Journal of Psychiatry
por: van Staden, Werdie C.W.
Publicado: (2017)

Patients’ voices from music therapy at a South African psychiatric hospital
por: Lotter, Carol, et al.
Publicado: (2022)

Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
por: Dodgen, Tyren M, et al.
Publicado: (2013)

CYP2D6 polymorphisms and their influence on risperidone treatment
por: Puangpetch, Apichaya, et al.
Publicado: (2016)

The professionalism of psychiatry registrars as perceived by patients and various health practitioners at Weskoppies Psychiatric Hospital, Pretoria
por: Banda, Matthews M., et al.
Publicado: (2018)

CYP2D6 genotype and adverse events to risperidone in children and adolescents
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia
por: Naidu, Kalai, et al.
Publicado: (2014)

Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
por: Lu, Jinjun, et al.
Publicado: (2021)

Algorithmic Assessments in Deciding on Voluntary, Assisted or Involuntary Psychiatric Treatment
por: Grobler, Gerhard, et al.
Publicado: (2022)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population
por: Huo, Ran, et al.
Publicado: (2012)

Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia
por: Naidu, Kalai, et al.
Publicado: (2020)

Inequitable access to healthcare in Africa: reconceptualising the “accountability for reasonableness framework” to reflect indigenous principles
por: Ujewe, Samuel J., et al.
Publicado: (2021)

Validity and Reliability of the Staden Schizophrenia Anxiety Rating Scale
por: Van Staden, Werdie, et al.
Publicado: (2022)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Kumar, P.N. Suresh
Publicado: (1999)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Pandey, S.K.
Publicado: (1999)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
por: Ito, Takahiro, et al.
Publicado: (2018)

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients
por: Lenk, Hasan Çağın, et al.
Publicado: (2022)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
por: Cui, Yuanxia, et al.
Publicado: (2020)

Pharmacogenetics of CYP2A6, CYP2B6, and UGT2B7 in the Context of HIV Treatments in African Populations
por: Ford, Graeme R., et al.
Publicado: (2022)

Adverse Drug Reactions Associated with CYP 2B6 Polymorphisms in HIV/AIDS-Treated Patients in Yaoundé, Cameroon
por: Nguefeu Nkenfou, Carine, et al.
Publicado: (2019)

Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients
por: Lee, Fei Yee, et al.
Publicado: (2022)

A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia
por: Chavan, Bir S., et al.
Publicado: (2018)

Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (–141 C Ins/Del) and 5HTR2C (–759 C>T) Genetic Polymorphisms in Patients with Schizophrenia
por: Alladi, Charanraj Goud, et al.
Publicado: (2017)

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
por: Dodsworth, Thomas, et al.
Publicado: (2018)

Beyond Body Mass Index: Are Weight-loss Programs the Best Way to Improve the Health of African American Women?
por: Dodgen, Leilani, et al.
Publicado: (2017)

Debate: The concept of culture has outlived its usefulness for psychiatry
por: Rashed, Mohammed A., et al.
Publicado: (2018)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer
por: Tan, Tingfei, et al.
Publicado: (2022)

High energy (p,2p) reactions and proton binding energies
por: Tyrén, H, et al.
Publicado: (1958)

Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
por: Almoguera, B, et al.
Publicado: (2013)

Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Use of the Charge Transfer Reactions for the Spectrophotometric Determination of Risperidone in Pure and in Dosage Forms
por: Deepakumari, Hemavathi Nagaraju, et al.
Publicado: (2013)

Genetic Polymorphisms in Dopamine- and Serotonin-Related Genes and Treatment Responses to Risperidone and Perospirone
por: Tsutsumi, Atsushi, et al.
Publicado: (2009)

Association Study of KCNH7 Polymorphisms and Individual Responses to Risperidone Treatment in Schizophrenia
por: Wang, Xueping, et al.
Publicado: (2019)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_h5i7k0anv0fvqlhv63bn16ms55